Krisztian Homicsko receives imFLAME award from the Genentech/Roche imCORE foundation

All our congratulations go to Dr. Krisztian Homicsko, who is the proud winner of the 2022 imFLAME Investigator Award !

imFLAME is the early career network of imCORE – a global network of basic and clinical scientists from 21 leading academic research institutions in cancer immunotherapy. Working together with scientists from Roche and Genentech, imFLAME members pursue the goal of developing potential cures for people with cancer, focusing on existing and new investigational medicines, diagnostic technologies and emerging data. The network closely collaborates to identify and prioritise the most promising new treatment approaches and to rapidly conduct clinical trials to accelerate progress in the field.

The award ceremony took place at the 2022imCORE meeting of Genentech in Amsterdam.